Key Points Details Purpose of Insurance Exclusions Control risk exposure and avoid unnecessary protection for preventable issues or high-risk situations. Common Exclusions Catastrophic Events Intentional Acts Maintenance Issues Illegal Activities Types of Exclusions Catastrophic Exclusions Intentional Acts Maintenance and Neglect Acts of War and Terrorism Natural Disasters Strategies to Navigate Exclusions Read Your Policy Carefully Ask Questions Purchase Additional Coverage Maintain Your Property Conclusion Understand and identify exclusions to manage risks effectively and ensure comprehensive protection. Navigating Insurance Exclusions: Understanding Your Policy Rights and Challenges Insurance serves as a crucial mechanism for managing risks, but the nuances of what is covered and what isn't can be confusing due to exclusions. This article aims to demystify insurance exclusions, explain their purpose, and provide strategies to effectively navigate these barriers. What Are Insurance Exclusions? Insurance exclusions are clauses detailing scenarios or events that a policy will not cover. These are put in place to control the risk exposure of insurers and ensure policyholders don't receive unnecessary protection for preventable issues or high-risk situations. Examples of Common Exclusions Catastrophic Events: Events like floods, earthquakes, and wars are typically excluded due to their potential for extensive damage and the high costs involved [1]. Intentional Acts: Damages from intentional acts, like vandalism or arson, often result in exclusions to prevent fraud [1]. Maintenance Issues: Issues arising from negligence or lack of maintenance, such as not insulating pipes, are commonly excluded [2]. Illegal Activities: Engaging in illegal acts is usually not covered by insurance [1]. Types of Insurance Exclusions 1. Catastrophic Exclusions These exclusions involve events like natural disasters and wars. Because these events can cause extensive damage, separate policies, like flood insurance through the National Flood Insurance Program, might be necessary [1]. 2. Intentional Acts Excluding intentional acts is a deterrent against fraudulent claims. This type of exclusion ensures the integrity of the insurance system [2]. 3. Maintenance and Neglect Exclusions Policies typically require property owners to perform regular maintenance. For instance, failure to replace air filters leading to damage could result in an exclusion from coverage [2]. 4. Acts of War and Terrorism Most policies exclude acts of war and terrorism given the unpredictable nature and potential for widespread destruction [3]. 5. Natural Disasters Excluded from standard homeowner policies, these include floods and earthquakes, especially where risk is significant [3]. How to Navigate Insurance Exclusions Read Your Policy Carefully Understanding exclusions begins with a thorough review of your policy. Knowing what isnt covered helps you decide if additional coverage is necessary. Ask Questions Dont hesitate to reach out to your insurer for clarification on any exclusion so you can make informed decisions about your coverage options. Purchase Additional Coverage Consider buying additional riders or standalone policies for risks excluded from your primary policy. For equestrians, this might mean ensuring coverage for gear or health. Maintain Your Property Regular property maintenance can prevent exclusions tied to neglect. A well-kept stable, for instance, can mitigate risks of unintentional damage. Conclusion Understanding insurance exclusions is vital for managing risks effectively. By identifying exclusions in your policy, you can better prepare to manage unexpected events. The key is to actively engage with your policy, regularly review and adjust your coverage, and seek additional protection when necessary. Your aim should be comprehensive protection that accommodates you and your needs.```html```

Osteoarthritis is one of the leading causes of performance loss in equine athletes. | iStockJoint pain and osteoarthritis (OA) represent one of the leading causes of performance loss in equine athletes, affecting around 60% of the overall population. Chronic inflammation may cause permanent changes in joint function, leading to long-term pain, swelling and decreased range of motion, among other debilitating symptoms.Many of the current OA treatments are management tools that prolong function, generally without modifying OA progression. The most common treatments include non-steroidal anti-inflammatory drugs (NSAIDs) and oral joint supplements that target cartilage repair or protective pathways, as well as joint injections with corticosteroids or newer orthobiologics, both of which are anti-inflammatory. Unfortunately, many of these treatments are associated with other adverse effects, especially when used long-term.Several novel treatments to reduce joint inflammation with minimal side effects have been proposed within the scientific community. One such treatment is cannabidiol (CBD), a non-psychoactive chemical compound found in Cannabis sativa (colloquially known as hemp). CBD is known to target the endocannabinoid system, a complex network of several biological systems that affects many physiological processes, including but not limited to, pain perception, appetite, mood, learning and immune function. Within the context of OA, CBD has been found to inhibit the production of substances that increase inflammation, decrease sensitivity of pain-associated receptors and modulate an overactive immune system. Anecdotally, many people claim the benefits of CBD, but more research is required to accurately quantify and qualify its potential benefits and risks. This is especially true within the equine community.Our work in the Page Laboratory is interested in understanding the potential anti-inflammatory effects of CBD in joints via the implementation of a three-phase project. We aim to improve a chemically induced joint inflammation model such that it will be repeatable and reversible, while still accurately mimicking the bodys physical and biochemical response to inflammation.Phase one involves refining the dosage of a proinflammatory compound which will be injected into one knee (carpal) joint, inducing temporary inflammation. Defining an appropriate dosage protocol and taking note of individual horse variability is an important step for developing a reliable experimental procedure.Following phase one, the aim of phase two is to identify an appropriate CBD formulation for oral administration. Due to its chemical composition, CBD is not well absorbed by the equine GI tract, with a bioavailability around 10% (e.g. horses will only absorb about 10% of the CBD administered to them). Previous research has found what a drug is dissolved in can make a large difference in systemic CBD levels, and the most effective candidates are usually composed of fats, such as sesame or canola oil. An optimized formulation is necessary to both maximize therapeutic benefit while keeping palatability in mind for horses.In phase three, we will combine the findings from the first two phases and analyze the effects of CBD on the drug-induced inflammatory response. A control group will receive no CBD, and the differences between the treated and untreated group will be evaluated. Horses will be evaluated for several parameters, including the presence of biomarkers associated with inflammation both within the joint and systemically throughout the body. The mild lameness that is induced will be quantified via an objective evaluation system that can better detect the subtleties of gait asymmetries when compared to the human eye.While other researchers have shown that CBD represents an exciting prospect for the treatment of chronic joint pain, our research should provide additional information on its efficacy for the horse. Our findings may find applications for human medicine given the mechanisms of OA and joint pain in humans often mimic those seen in horses, which is important given that approximately 45% of people will develop some form of OA within their lifetimes. In the end, we hope to provide a better research model for joint inflammation while simultaneously evaluating CBD as a way to manage joint pain in horses.Editors note: This is an excerpt from Equine Disease Quarterly, Vol. 34, Issue 1, funded by underwriters at Lloyds, London, brokers, and their Kentucky agents. It was written by Jenna McPeek, PhD Graduate Student at the University of Kentuckys Gluck Equine Research Center, in Lexington and Allen Page, DVM, PhD, assistant professor and faculty advisor at the Gluck Equine Research Center.

Athlete Selection Policy FEI Pony European Jumping Championships, CH-EU-P-S, Le Mans (FRA) 28th July 3rd August 2025 Relevant Documentation: Please see below Pony Eventing Selection Policy for 2025, in addition relevant appendix CH-EU-P-S, Le Mans (FRA)_Athlete Selection Policy 2025 Appendix 1 HSI Code of Conduct Athletes Appendix 2 Horse Sport Ireland Social Media Policy Appendix 3 2024-HSI-Medication-Equine-Anti-Doping-Updated FEB 2023

Athlete Selection Policy FEI European Jumping Championships for Juniors and Children Riesenbeck (GER) 7th 13th July 2025 CH-EU-J-S CH-EU-Ch-S Relevant Documentation: Please see below Pony Eventing Selection Policy for 2025, in addition relevant appendix CH-EU-Ch-S Riesenbeck (GER) Athlete Selection Policy 2025 Appendix 1 HSI Code of Conduct Athletes Appendix 2 Horse Sport Ireland Social Media Policy Appendix 3 2024-HSI-Medication-Equine-Anti-Doping-Updated FEB 2023

Horse Sport Ireland (HSI) has begun to receive applications for 2025 foal passports through the Horse Source online passporting system. From today, May 2nd, updated figures on passporting will be published fortnightly to keep breeders informed on the overall status of the processing of applications. For the 2025 breeding season so far, HSI has received 161 applications and issued four completed applications. From these 161 applications, 160 are with pedigree, with one non-pedigree application received. 146 pedigree applications have had their foal kit sent to the applicant, with the remainder issued imminently. It is important to note that, to date, 137 foal kits have not been yet returned from breeders to HSI for pedigree applications. Of the nine applications who have returned their foal kits to HSI, four have been completed and the passport issued, while the remaining fives DNA samples are currently with the laboratory for analysis. All []